New thrombolytic, anticoagulants, and platelet antagonists: The future of clinical practice

被引：9
作者：
Becker, RC [1 ]
机构：
[1] Univ Massachusetts, Med Ctr, Cardiovasc Thrombosis Res Ctr, Worcester, MA 01655 USA
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 1999年 / 7卷 / 02期
关键词：
D O I：
10.1023/A:1008845822884
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：195 / 220
页数：26
相关论文
共 125 条
[71]  
LOCKNER D, 1989, THROMB HAEMOSTASIS, V62, P526
[72]  
LOPACIUK S, 1992, THROMB HAEMOSTASIS, V68, P14
[73]  
MAGNANI HN, 1993, THROMB HAEMOSTASIS, V70, P554
[74]  
MASSONNETCASTEL S, 1986, HAEMOSTASIS, V16, P139
[75]   COMPARISON OF EFFICACY OF LOW-MOLECULAR-WEIGHT HEPARIN (PARNAPARIN) WITH THAT OF UNFRACTIONATED HEPARIN IN THE PRESENCE OF ACTIVATED PLATELETS IN HEALTHY-SUBJECTS [J].
MELANDRI, G ;
SEMPRINI, F ;
CERVI, V ;
CANDIOTTI, N ;
BRANZI, A ;
PALAZZINI, E ;
MAGNANI, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) :450-454
[76]  
MILETICH JP, 1978, J BIOL CHEM, V253, P6908
[77]  
MORICE MC, 1994, CIRCULATION, V90, P125
[78]   Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men [J].
Muller, TH ;
Weisenberger, H ;
Brickl, R ;
Narjes, H ;
Himmelsbach, F ;
Krause, J .
CIRCULATION, 1997, 96 (04) :1130-1138
[79]   SAFETY OF HIGH-DOSES OF LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) IN ACUTE MYOCARDIAL-INFARCTION - A DOSE-FINDING STUDY [J].
NESVOLD, A ;
KONTNY, F ;
ABILDGAARD, U ;
DALE, J .
THROMBOSIS RESEARCH, 1991, 64 (05) :579-587
[80]   DOSE-FINDING WITH A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR (BM-06.022) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE GERMAN RECOMBINANT PLASMINOGEN-ACTIVATOR STUDY [J].
NEUHAUS, KL ;
VONESSEN, R ;
VOGT, A ;
TEBBE, U ;
RUSTIGE, J ;
WAGNER, HJ ;
APPEL, KF ;
STIENEN, U ;
KONIG, R ;
MEYERSABELLEK, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (01) :55-60
3456789101112